The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment
Abstract
Share and Cite
Alwahsh, M.; Alejel, R.; Hasan, A.; Abuzaid, H.; Al-Qirim, T. The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment. Metabolites 2024, 14, 438. https://doi.org/10.3390/metabo14080438
Alwahsh M, Alejel R, Hasan A, Abuzaid H, Al-Qirim T. The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment. Metabolites. 2024; 14(8):438. https://doi.org/10.3390/metabo14080438
Chicago/Turabian StyleAlwahsh, Mohammad, Rahaf Alejel, Aya Hasan, Haneen Abuzaid, and Tariq Al-Qirim. 2024. "The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment" Metabolites 14, no. 8: 438. https://doi.org/10.3390/metabo14080438
APA StyleAlwahsh, M., Alejel, R., Hasan, A., Abuzaid, H., & Al-Qirim, T. (2024). The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment. Metabolites, 14(8), 438. https://doi.org/10.3390/metabo14080438